Login / Signup
Data driven polypharmacological drug design for lung cancer: analyses for targeting ALK, MET, and EGFR.
Dilip Narayanan
Osman A. B. S. M. Gani
Franz X. E. Gruber
Richard A. Engh
Published in:
J. Cheminformatics (2017)
Keyphrases
</>
lung cancer
drug design
data driven
cancer diagnosis
drug discovery
protein structure prediction
survival prediction
protein protein interactions
quantitative structure activity
cancer cells
risk factors
lymph nodes
lung cancer patients
statistical analysis
pet ct
gene selection
feature selection
machine learning